济民药业,关爱无限 www.pidrug.com
香港济民药业微信二维码
198 9654 1773
当前位置:首页 > 药品资讯 > 精神科 > 加巴喷丁Gabapentin

加巴喷丁Gabapentin

[ 人气:63 | 日期: 2020-08-04 | 返回 | 打印 ]
加巴喷丁Gabapentin
药品名称:加巴喷丁Gabapentin
药品别名:
英 文 名:
药品价格:$ 美国市场售价 13.36 美元
研发公司:
适 用 症:用于难治的不全性癫痫
型号规格:每片含有效成份300mg,每瓶100片
药品详情:

【加巴喷丁Gabapentin 简述】
 
    加巴喷丁(Gabapentin)是一种新颖的抗癫痫药,它是γ-氨基丁酸(GABA)的衍生物,其药理作用与现有的抗癫痫药不同,研究表明加巴喷丁的作用是改变GABA代谢产生的。

加巴喷丁Gabapentin_香港济民药业
 
【加巴喷丁Gabapentin 适应症】
 
    加巴喷丁Gabapentin用于难治的不全性癫痫。
 
    抗焦虑药加巴喷丁(gabapentin)和抗病毒药伐昔洛韦(valacyclovir)联用可减少急性带状疱疹后遗神经痛的危险。
 
【加巴喷丁Gabapentin 规格】
 
    本品为片剂,每片含有效成份300mg,每瓶100片。
 
【加巴喷丁Gabapentin 服用方法】
 
    第一次睡前服300毫克。以后每天增加300毫克,用量可以高达每天3600毫克上述剂量需分三次服用。
 
【加巴喷丁Gabapentin 注意事项】
 
    对本药过敏者禁用。
 
    西咪替丁可降低加巴喷丁的肾脏清除率,抑酸药能使加巴喷丁的吸收率降低20%。
 
慎用于失神性发作、糖尿病,对本药过敏者,肾功能减退者和老年患者;禁用与急性胰腺炎患者;过量症状为严重腹泻、复视、严重的头晕、嗜睡、口齿不清、甚至死亡;如换药或停药应逐渐量,至少1周内逐步进行;最好不与抗酸药合用。服用抗酸药2小时后才能服用本药;服用牛奶后也可出现假性蛋白尿和白细胞减少。
 
女性用药
 
(1)妊娠危险分级:C级。
 
(2)哺乳:该药可从乳汁分泌,但对哺乳婴儿的影响不明。
 
(3)与激素类避孕药的相互作用:无。
 
(4)其他:多囊卵巢综合症发生的危险与体重增加有关,因此体重增加的不良反应对女性更重要。
 
【加巴喷丁Gabapentin 不良反应】
 
    包括嗜睡,眩晕,行走不稳,疲劳感。这些副作用常见于用药早期。只要从小剂量开始,缓慢地增加剂量,多数人都能耐受。儿童偶尔会急躁易怒,停药以后会消失。
 
    常见:食欲和体重增加是一个问题。其他的不良反应包括:头晕、共济失调、眼球震颤、头痛、震颤、乏力、复视、鼻炎、恶心。明显行为紊乱,如攻击性、兴奋易怒,主要报告在儿童出现。既往有精神疾病病史的患者慎用。
 
(1)可能产生严重不良反应:较罕见,具体的发生率如下,皮疹(0.5%)、白细胞减少(0.2%)、心电图改变和心绞痛(0.05%)。
 
(2)加巴喷丁会引发重症肌无力患者出现症状,这类患者要慎用。
 
(3)癫痫加重:加巴喷丁治疗中可能突现癫痫加重的情况,特别是全身性发作患者。

 
Gabapentin
 
Gabapentin, sold under the brand name Neurontin among others, is an anticonvulsant medication used to treat partial seizures, neuropathic pain, hot flashes, and restless legs syndrome.[4][5] It is recommended as one of a number of first-line medications for the treatment of neuropathic pain caused by diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.[6] About 15% of those given gabapentin for diabetic neuropathy or postherpetic neuralgia have a measurable benefit.[7] Gabapentin is taken by mouth.[4]
 
Common side effects include sleepiness and dizziness.[4] Serious side effects include an increased risk of suicide, aggressive behavior, and drug reactions.[4] It is unclear if it is safe during pregnancy or breastfeeding.[8] Lower doses are recommended in those with kidney disease associated with a low kidney function.[4] Gabapentin is a gabapentinoid.[9] It has a molecular structure similar to that of the neurotransmitter γ-aminobutyric acid (GABA) and acts by inhibiting certain calcium channels.[10][9][11]
 
Gabapentin was first approved for use in 1993.[12] It has been available as a generic medication in the United States since 2004.[4] The wholesale price in the developing worldas of 2015 was about US$10.80 per month;[13] in the United States, it was US$100 to US$200.[14] In 2016, it was the 11th most prescribed medication in the United States, with more than 44 million prescriptions.[15] During the 1990s, Parke-Davis, a subsidiary of Pfizer, began using a number of illegal techniques to encourage physicians in the United States to use gabapentin for unapproved uses.[16] They have paid out millions of dollars to settle lawsuits regarding these activities.[17]
 
Medical uses
 
Gabapentin is FDA approved to treat seizures and neuropathic pain.[18][19][20] It is primarily administered by mouth, with a study showing that "rectal administration is not satisfactory".[21] It is also commonly prescribed for many off-label uses, such as treatment of anxiety disorders,[22][23] insomnia, and bipolar disorder.[22] About 90% of usage is for off-label conditions.[20] There are, however, concerns regarding the quality of the trials conducted and evidence for some such uses, especially in the case of its use as a mood stabilizer in bipolar disorder.[24]
Seizures
Gabapentin is approved for treatment of focal seizures[25] and mixed seizures. There is insufficient evidence for its use in generalized epilepsy.[26]
Neuropathic pain
A 2018 review found that gabapentin was of no benefit in sciatica nor low back pain.[27]
 
A 2010 European Federation of Neurological Societies task force clinical guidelinerecommended gabapentin as a first-line treatment for diabetic neuropathy, postherpetic neuralgia, or central pain. It found good evidence that a combination of gabapentin and morphine or oxycodone or nortriptyline worked better than either drug alone; the combination of gabapentin and venlafaxine may be better than gabapentin alone.[6]
 
A 2017 Cochrane review found evidence of moderate quality showing a reduction in pain by 50% in about 15% of people with postherpetic neuralgia and diabetic neuropathy.[7]Evidence finds little benefit and significant risk in those with chronic low back pain.[28] It is not known if gabapentin can be used to treat other pain conditions, and no difference among various formulations or doses of gabapentin was found.[7]
 
A 2010 review found that it may be helpful in neuropathic pain due to cancer.[29] It is not effective in HIV-associated sensory neuropathy[30] and does not appear to provide benefit for complex regional pain syndrome.[31]
 
A 2009 review found gabapentin may reduce opioid use following surgery, but does not help with post-surgery chronic pain.[32] A 2016 review found it does not help with pain following a knee replacement.[33]
 
It appears to be as effective as pregabalin for neuropathic pain and costs less.[34] All doses appear to result in similar pain relief.[35]
Migraine
The American Headache Society (AHS) and American Academy of Neurology (AAN) guidelines classify gabapentin as a drug with "insufficient data to support or refute use for migraine prophylaxis".[36] A 2013 Cochrane review concluded that gabapentin was not useful for the prevention of episodic migraine in adults.[37]
Anxiety disorders
Gabapentin has been used off-label for the treatment of anxiety disorders. However, there is dispute over whether evidence is sufficient to support it being routinely prescribed for this purpose.[22][23][38][39] While pregabalin may have efficacy in the treatment of refractory anxiety in people with chronic pain, it is unclear if gabapentin is equally effective.[40]
Other uses
Gabapentin may be useful in the treatment of comorbid anxiety in bipolar patients; however, it is not effective as a mood-stabilizing treatment for manic or depressive episodes themselves.[24][41][42][22] Other psychiatric conditions, such as borderline personality disorder, have also been treated off-label with gabapentin.[20] There is insufficient evidence to support its use in obsessive–compulsive disorder and treatment-resistant depression.[43]
 
Gabapentin may be effective in acquired pendular nystagmus and infantile nystagmus (but not periodic alternating nystagmus).[44][45] It is effective for treating hot flashes.[46][47][48] It may be effective in reducing pain and spasticity in multiple sclerosis.[49]
 
Gabapentin may reduce symptoms of alcohol withdrawal (but it does not prevent the associated seizures), alcohol dependence and craving.[50][43] There is some evidence for its role in the treatment of alcohol use disorder; the 2015 VA/DoD guideline on substance use disorders lists gabapentin as a "weak for" and is recommended as a second-line agent.[51]Use for smoking cessation has had mixed results.[52][53] There is insufficient evidence for its use in cannabis dependence.[54]
 
Gabapentin is effective in alleviating itching in kidney failure (uremic pruritus)[55] and itching of other causes.[56] It is an established treatment of restless legs syndrome.[57] Gabapentin may help sleeping problems in people with restless legs syndrome and partial seizures due to its increase in slow-wave sleep and augmentation of sleep efficiency.[58][59][60] Gabapentin may be an option in essential or orthostatic tremor.[61][62][63] Gabapentin does not appear effective for the treatment of tinnitus.[64]
 
Overdose
 
Through excessive ingestion, accidental or otherwise, persons may experience overdose symptoms including drowsiness, sedation, blurred vision, slurred speech, somnolence, uncontrollable jerking motions, anxiety and possibly death, if a very high amount was taken, particularly if combined with alcohol. For overdose considerations, serum gabapentin concentrations may be measured for confirmation.[79]
 




注:药品如有新包装,以新包装为准。以上资讯仅供医护人员内部讨论,不作任何用药依据,具体用药指引,请咨询主治医师。

更多相关资讯:返回顶部
最新药品资讯
  • Venclyxto(维奈妥拉)联合MabThera治疗慢淋白血病,患者死亡风险降低!
  • Tagrisso(Osimertinib)在英国获批用于两种肺癌适应症的治疗
  • ziritaxestat治疗弥漫性皮肤系统性硬化症(dcSSc)2期概念验证研究成功!
  • 美国FDA批准GSK三联疗法:可同时治疗哮喘和慢阻肺
  • NBIb-1817一次性治疗帕金森病(PD)显著改善运动功能、延长ON时间
  • 口服抗生素tebipenem HBr治疗cUTI和AP关键III期临床成功,疗效不劣于ertapenem
  • 下一代选择性免疫调节剂IMU-838治疗多发性硬化症(RRMS)具有显著疗效,有良好的安全性和耐受性!
  • Fintepla(芬氟拉明)口服溶液治疗Dravet综合征相关癫痫的第三项3期研究结果:抽搐发作显著减少
  • 视神经脊髓炎谱系障碍(NMOSD)创新药Enspryng(satralizumab)获美FDA批准
  • Fasenra与标准类固醇同时治疗鼻息肉三期临床结果积极
  • Darzalex Faspro申请新适应症,治疗轻链(AL)淀粉样变性!
  • 地诺单抗(Xgeva,denosumab)治疗实体瘤骨转移疗效怎样?
  • 新药IDH1抑制剂Tibsovo治疗胆管癌效果怎么样?
  • 拜耳Nubeqa(达罗他胺)治疗非转移性去势抵抗性前列腺癌显著延长患者生存!
  • FDA对罗氏Tecentriq治疗三阴性乳腺癌研究发出警告!
  • 加码多发性硬化症!罗氏启动三项临床试验研究
  • Xeglyze说明书-价格-功效与作用-副作用
  • 赛诺菲/再生元Dupixent(达必妥®)显著延缓哮喘患者肺功能下降:疗效维持3年!
  • 默沙东止咳药gefapixant2项关键III期临床试验成功:咳嗽频率显著降低
  • Ryplazim(纤溶酶原)再次申请上市:首个先天性纤溶酶原缺乏症(C-PLGD)治疗药物!
  • 拜耳Adempas用于经PDE5i治疗反应不足的肺动脉高压(PAH)患者IV期临床成功
  • Midostaurin(米哚妥林)适应症是什么?优势在哪里?
  • 艾普利Apixaban可以在哪里买到正品?
  • 维奈妥拉/维奈托克(VENETOCLAX)怎么服用?注意事项是什么?
  • 芦可替尼Ruxolitinib治疗特应性皮炎效果好不好?
  • 巯嘌呤片(6-MP)Puri-nethol治疗急性白血病效果如何?
  • 晚期HCC患者能从Ramucirumab中获益吗?
  • 赫赛汀+拉帕替尼治疗乳腺癌效果更好
  • 欧盟批准Imfinzi(英飞凡):一线治疗广泛期小细胞肺癌(ES-SCLC)!
  • 第三代强效COMT抑制剂Ongentys(opicapone)用于治疗帕金森病(PD)的新药在日本上市!


  • 如您发现本网站有文字编辑或内容错误,请点击此处发送(需要安装有foxmail或outlook支持),


    或发邮件至:info@morecare.hk,香港济民药业感谢您的到访!


    欢迎您添加香港济民药业微信,或在公众号内留言。

    香港济民微信公众号
    • 香港济民药业友情链接
    • 友情链接

    联系我们:

    地址:
    Rm. 314, Sun Ling Plaza, 30 On Kui Street, Fanling, HONG KONG
    邮箱:
    info@pidrug.com
    电话:
    198 9654 1773
    粤ICP备17150936号
    香港济民药业官方网站
    • 关注我们 :
    • 香港济民药业微博
    • 关注香港济民药业博客
    • 香港济民药业微信公众号